Prehospital notification can effectively reduce in-hospital delay for thrombolysis in acute stroke

IF 0.6 Q4 CLINICAL NEUROLOGY

Future Neurology Pub Date : 2018-02-01 DOI:10.2217/FNL-2017-0031

Elyar Sadeghi-Hokmabadi, M. Farhoudi, A. Taheraghdam, R. Rikhtegar, R. Ghafouri, Rogayyeh Asadi, Elham Mehdizadeh Far, N. Ghaemian, Mehrdad Mehrara, Reshad Mirnour

引用次数: 6

Abstract

Aim: To reduce in-hospital intervals by developing a prehospital notification (PHN) protocol which directly notifies a neurologist to prepare for possible treatment. Methods: A 24/7 connection was established between emergency medical services dispatch and the on-call neurologist. A database of all patients with in-hospital stroke code activation was developed, door-to-computed tomography (CT) time and door-to-needle time was recorded from January 2013 to December 2016. The statistical results were considered significant at p < 0.05. Result: PHN resulted in a significant reduction in door-to-CT time (median 14 vs 20; p < 0.001). Among patients who were treated with intravenous thrombolysis, door-to-needle time was significantly shorter in patients with PHN compared with non-PHN group (median 42 vs 70; p < 0.001). Conclusion: PHN effectively reduced door-to-CT and door-to-needle times. © 2018 2018 Reshad Mirnour.

查看原文本刊更多论文

院前告知可有效减少急性脑卒中溶栓的住院延误

目的:通过制定院前通知(PHN)协议，直接通知神经科医生为可能的治疗做准备，以减少住院间隔。方法:在紧急医疗服务调度和随叫随到的神经科医生之间建立全天候的联系。建立了所有院内卒中代码激活患者的数据库，记录了2013年1月至2016年12月期间门对计算机断层扫描(CT)时间和门对针头时间。p < 0.05为差异有统计学意义。结果:PHN可显著缩短门静脉到ct的时间(中位14 vs 20;P < 0.001)。在接受静脉溶栓治疗的患者中，PHN患者从门到针的时间明显短于非PHN组(中位数42 vs 70;P < 0.001)。结论:PHN可有效减少门到ct和门到针的次数。©2018 2018 Reshad mirour。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Future Neurology CLINICAL NEUROLOGY-

CiteScore

2.10

自引率

0.00%

发文量

期刊介绍： The neurological landscape is changing rapidly. From the technological perspective, advanced molecular approaches and imaging modalities have greatly increased our understanding of neurological disease, with enhanced prospects for effective treatments in common but very serious disorders such as stroke, epilepsy, multiple sclerosis and Parkinson’s disease. Nevertheless, at the same time, the healthcare community is increasingly challenged by the rise in neurodegenerative diseases consequent upon demographic changes in developed countries.